Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KYNU | Q16719 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.51 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.51 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 5/20 | 0.49 |
| ▸ | CTSS | P25774 | 4/20 | 0.48 |
| ▸ | CTSL | P07711 | 3/20 | 0.48 |
| ▸ | CTSB | P07858 | 2/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.47 |
| ▸ | TACR1 | P25103 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20556402 | 1.00 | KYNU (0.55) | KYNUALDH1A1ALOX15SIRT2SIRT1 | |
| SCHEMBL28723315 | 0.91 | CTSK (0.50) | KYNUALDH1A1ALOX15SIRT2SIRT1 | |
| SCHEMBL28723314 | 0.91 | CTSK (0.50) | KYNUALDH1A1ALOX15SIRT2SIRT1 | |
| SCHEMBL4971022 | 0.88 | KYNU (0.57) | KYNUALDH1A1ALOX15CTSKCTSS | |
| SCHEMBL29262796 | 0.86 | KYNU (0.64) | KYNUALDH1A1ALOX15SIRT2SIRT1 | |
| SCHEMBL22637635 | 0.86 | KYNU (0.64) | KYNUALDH1A1ALOX15SIRT2SIRT1 | |
| SCHEMBL23000174 | 0.85 | CA2 (0.50) | CA1CA2CTSKCTSSCTSL | |
| SCHEMBL20553378 | 0.85 | CA2 (0.50) | CA1CA2CTSKCTSSCTSL | |
| SCHEMBL24012785 | 0.84 | CTRB1 (0.50) | KYNUALDH1A1ALOX15CA1CA2 | |
| SCHEMBL8671689 | 0.84 | SIRT2 (0.53) | SIRT2SIRT1CTSKCTSSCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024198077-A1 | AMINO ACID DERIVATIVE AND PREPARATION METHOD THEREFOR, AND METHOD FOR USING AMINO ACID DERIVATIVE AS INTERMEDIATE TO SYNTHESIZE L-GLUFOSINATE-AMMONIUM | 南京华狮新材料有限公司 | 2024-10-03 | — | — | WO | disclosed |
| CN-118724766-A | Amino acid derivative, preparation method thereof and method for synthesizing L-glufosinate-ammonium as intermediate | 南京华狮新材料有限公司 | 2024-10-01 | — | — | CN | disclosed |
| EP-3377473-B1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2024-06-19 | — | — | EP | disclosed |
| US-20230133817-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| US-20180327367-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | WUXI APPTEC CO., LTD (CN) | 2018-11-15 | — | — | US | disclosed |
| US-7750162-B2 | Process for preparation of nonnatural amino acid and intermediate thereof | DAISO CO., LTD. (JP) | 2010-07-06 | — | — | US | disclosed |
| US-20070208180-A1 | Process for Preparation of Nonnatural Amino Acid and Intermediate Thereof | DAISO CO., LTD. (JP) | 2007-09-06 | — | — | US | disclosed |
| EP-1739077-A1 | PROCESS FOR PRODUCTION OF NONNATURAL AMINO ACIDS AND INTERMEDIATES THEREFOR | DAISO CO., LTD. (JP) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208180-A1 | Process for Preparation of Nonnatural Amino Acid and Intermediate Thereof | BCAT1, BCAT2, AADAT | KYNU 32/4885ALDH1A1 852/4885ALOX15 607/4885 |
| US-20180327367-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | KYNU 2204/4885ALDH1A1 2364/4885ALOX15 3654/4885 |
| US-20230133817-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | KYNU 2204/4885ALDH1A1 2364/4885ALOX15 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.